CN110105447A - 一种猪伪狂犬病病毒高免血清的制备方法 - Google Patents
一种猪伪狂犬病病毒高免血清的制备方法 Download PDFInfo
- Publication number
- CN110105447A CN110105447A CN201910366836.6A CN201910366836A CN110105447A CN 110105447 A CN110105447 A CN 110105447A CN 201910366836 A CN201910366836 A CN 201910366836A CN 110105447 A CN110105447 A CN 110105447A
- Authority
- CN
- China
- Prior art keywords
- pseudorabies virus
- interferon
- plants
- porcine pseudorabies
- buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002966 serum Anatomy 0.000 title claims abstract description 41
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- 230000000521 hyperimmunizing effect Effects 0.000 title claims abstract description 24
- 241000196324 Embryophyta Species 0.000 claims abstract description 21
- 230000000091 immunopotentiator Effects 0.000 claims abstract description 17
- 229940031551 inactivated vaccine Drugs 0.000 claims abstract description 15
- 102000003996 Interferon-beta Human genes 0.000 claims abstract description 14
- 108090000467 Interferon-beta Proteins 0.000 claims abstract description 14
- 230000003053 immunization Effects 0.000 claims abstract description 14
- 238000002649 immunization Methods 0.000 claims abstract description 14
- 229960001388 interferon-beta Drugs 0.000 claims abstract description 14
- 241001061264 Astragalus Species 0.000 claims abstract description 11
- 235000006533 astragalus Nutrition 0.000 claims abstract description 11
- 210000004233 talus Anatomy 0.000 claims abstract description 11
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 claims abstract description 9
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 claims abstract description 9
- 231100000614 poison Toxicity 0.000 claims abstract description 7
- 239000002574 poison Substances 0.000 claims abstract description 7
- 230000036039 immunity Effects 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 26
- 241000700605 Viruses Species 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 229960005486 vaccine Drugs 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 12
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 230000002779 inactivation Effects 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 239000012475 sodium chloride buffer Substances 0.000 claims description 6
- 210000002540 macrophage Anatomy 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 238000005352 clarification Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims description 2
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 238000011068 loading method Methods 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 abstract description 5
- 238000012360 testing method Methods 0.000 description 11
- 241000282898 Sus scrofa Species 0.000 description 10
- 238000001514 detection method Methods 0.000 description 7
- 238000006386 neutralization reaction Methods 0.000 description 7
- 230000000937 inactivator Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 4
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 4
- 239000009636 Huang Qi Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000710777 Classical swine fever virus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- 241001533384 Circovirus Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241001673669 Porcine circovirus 2 Species 0.000 description 2
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 2
- 231100000645 Reed–Muench method Toxicity 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000000003 hoof Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 208000009305 pseudorabies Diseases 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000003501 vero cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910366836.6A CN110105447A (zh) | 2019-04-30 | 2019-04-30 | 一种猪伪狂犬病病毒高免血清的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910366836.6A CN110105447A (zh) | 2019-04-30 | 2019-04-30 | 一种猪伪狂犬病病毒高免血清的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110105447A true CN110105447A (zh) | 2019-08-09 |
Family
ID=67488205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910366836.6A Pending CN110105447A (zh) | 2019-04-30 | 2019-04-30 | 一种猪伪狂犬病病毒高免血清的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110105447A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094339A (zh) * | 2020-09-27 | 2020-12-18 | 中国兽医药品监察所 | 一种猪圆环病毒2型阳性血清及其制备方法 |
CN112522212A (zh) * | 2020-12-16 | 2021-03-19 | 湖北省农业科学院畜牧兽医研究所 | 一种猪流行性腹泻病毒株及其灭活疫苗与干扰素联合免疫方法 |
CN112679606A (zh) * | 2020-12-31 | 2021-04-20 | 天津瑞普生物技术股份有限公司 | 一种猪丹毒丝菌高免血清及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105732807A (zh) * | 2016-02-24 | 2016-07-06 | 福州大北农生物技术有限公司 | 一种猪伪狂犬病病毒阳性血清的制备方法 |
US20160228538A1 (en) * | 2015-02-11 | 2016-08-11 | Zhaoqing Dahuanong Biological Medicine Co., Ltd | Porcine Pseudorabies Virus (PRV)-YF Strain and Its Application |
CN107267466A (zh) * | 2017-07-04 | 2017-10-20 | 武汉科前生物股份有限公司 | 一种大规模生产猪伪狂犬病灭活疫苗的方法 |
-
2019
- 2019-04-30 CN CN201910366836.6A patent/CN110105447A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160228538A1 (en) * | 2015-02-11 | 2016-08-11 | Zhaoqing Dahuanong Biological Medicine Co., Ltd | Porcine Pseudorabies Virus (PRV)-YF Strain and Its Application |
CN105732807A (zh) * | 2016-02-24 | 2016-07-06 | 福州大北农生物技术有限公司 | 一种猪伪狂犬病病毒阳性血清的制备方法 |
CN107267466A (zh) * | 2017-07-04 | 2017-10-20 | 武汉科前生物股份有限公司 | 一种大规模生产猪伪狂犬病灭活疫苗的方法 |
Non-Patent Citations (1)
Title |
---|
王玉玲: "猪伪狂犬病病毒高免血清的制备及应用", 《福建畜牧兽医》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112094339A (zh) * | 2020-09-27 | 2020-12-18 | 中国兽医药品监察所 | 一种猪圆环病毒2型阳性血清及其制备方法 |
CN112522212A (zh) * | 2020-12-16 | 2021-03-19 | 湖北省农业科学院畜牧兽医研究所 | 一种猪流行性腹泻病毒株及其灭活疫苗与干扰素联合免疫方法 |
CN112679606A (zh) * | 2020-12-31 | 2021-04-20 | 天津瑞普生物技术股份有限公司 | 一种猪丹毒丝菌高免血清及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2250078C (en) | Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process | |
KR0156732B1 (ko) | 연속 셀 라인에서의 ibdv 생성 | |
CA2197683C (en) | Method for preparing an influenza virus, antigens obtained and applications thereof | |
Barteling | Development and performance of inactivated vaccines against foot and mouth disease | |
CN110105447A (zh) | 一种猪伪狂犬病病毒高免血清的制备方法 | |
Barteling | Modern inactivated foot-and-mouth disease (FMD) vaccines: historical background and key elements in production and use | |
NZ214984A (en) | Canine parvovirus vaccine | |
US8753646B2 (en) | IPV-DPT vaccine | |
CN104560890A (zh) | 一种h9亚型禽流感病毒及其应用 | |
Di Emidio et al. | Efficacy and safety studies on an inactivated vaccine against bluetongue virus serotype 2 | |
CN108452298A (zh) | 一种用spf鸡胚细胞生产黄热病减毒活疫苗的工艺 | |
CN105548536B (zh) | 一种猪乙型脑炎病毒抗体阳性血清的制备方法 | |
CN113304257A (zh) | 一种双佐剂新型冠状病毒灭活疫苗的制备方法及应用 | |
CN109097340A (zh) | 一种禽腺病毒、一种四联疫苗及其制备方法 | |
KR20020020260A (ko) | 서코바이러스를 생장시키거나 생물학적 물질로부터제거하는 방법 | |
RU2699671C1 (ru) | Вакцина для ранней защиты против ящура типа О инактивированная эмульсионная | |
CN102793920A (zh) | 复方免疫增强剂、禽用灭活疫苗及其制备方法 | |
CN104474542A (zh) | 一种二联灭活疫苗制备方法 | |
CN106563125B (zh) | 鸭甲肝病毒ⅲ型复合物活疫苗及其制备方法 | |
CN109055320A (zh) | 一株传染性支气管炎病毒分离株及在疫苗制备中的应用 | |
CN101610787A (zh) | 在培养物中复制流感病毒的方法 | |
CN109134646A (zh) | Ⅰ群血清4型禽腺病毒卵黄抗体的制备方法及其制品 | |
CN111686246A (zh) | 一种用于猪流行性腹泻病毒的抗原抗体复合物疫苗及其制备方法 | |
CN111057683A (zh) | 一种鸡胚接种用病毒稀释液及其制备方法和应用 | |
NZ234815A (en) | An attenuated canine parvovirus and vaccine containing it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant after: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: CHENGDU TECBOND BIOLOGICAL PRODUCTS CO.,LTD. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221208 Address after: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant after: Chengdu Shiji biopharmaceutical Co.,Ltd. Address before: No.358, lingchi street, Chengdu Economic and Technological Development Zone, Sichuan 610000 Applicant before: Chengdu Shiji biopharmaceutical Co.,Ltd. Applicant before: MA'ANSHAN SHIJI ANIMAL HEALTH MANAGEMENT Co.,Ltd. |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190809 |